all the information, none of the junk | biotech • healthcare • life sciences

$3M for IntelligentMDx

Xconomy Boston — 

IntelligentMDx, a Cambridge, MA, startup developing DNA- and RNA-based tests for a range of human diseases, announced last week that it has raised an additional $3 million from a group of unnamed, non-venture investors. The new funding brings the startup’s total capital pot to $26.5 million.